Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Update - NIH Response to Registration Issues in Sam.gov
National Institutes of Health - Notice of NIAID Participation in PA-18-393 "Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Clinical Trial Required)"
National Institute of Allergy and Infectious Diseases - Notice of Change in Funds Available and Anticipated Number of Awards for RFA-DA-19-002, "Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
National Institute on Drug Abuse - Notice of Correction of Peer Review and Council Dates in RFA-DC-19-001 NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
National Institute on Deafness and Other Communication Disorders - Notice of Clarification of Application Types Allowed for RFA-DK-18-012, Human Islet Research Enhancement Center for the Human Islet Research Network (U24 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases - FDA Standard Core Clinical Outcome Assessments and Endpoints
Food and Drug Administration - Vet-LIRN Network Capacity-Building Projects (U18)
Food and Drug Administration - Notice of Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences
National Institute of General Medical Sciences - Notice of Change to Criteria for RFA-HL-19-017 "NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases"
National Heart, Lung, and Blood Institute - Notice of Information to the Specific Areas of Research Interest for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)"
National Heart, Lung, and Blood Institute - AHRQ Implementation of the Burden-Reducing Provisions of the 2018 Common Rule
Agency for Healthcare Research and Quality - Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address the Opioids Crisis
Agency for Healthcare Research and Quality - Notice of NINR's Participation in NOT-AG-18-020 Notice to Extend the Expiration Date for PAR-18-027 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R01 Clinical Trial Optional)"
National Institute of Nursing Research - Notice of NINR's Participation in NOT-AG-18-021 Notice to Extend the Expiration Date for PAR-18-179 "Research on Informal and Formal Caregiving for Alzheimer's Disease (R21 Clinical Trial Optional)"
National Institute of Nursing Research - Notice of Pre-Application Webinar for the NIH Common Fund Somatic Cell Genome Editing program
Office of Strategic Coordination (Common Fund)
Requests for Applications
- Alzheimer Centers for Discovery of New Medicines (U54 Clinical Trial Not Allowed)
National Institute on Aging
- Genomic Innovator Award (R35 Clinical Trial Optional)
National Human Genome Research Institute
- Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
- Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed)
- Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
National Heart, Lung, and Blood Institute
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
. - Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
- Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Required - Infrastructure)
National Heart, Lung, and Blood Institute
- Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
- Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
National Institute on Minority Health and Health Disparities
National Institute of Mental Health
- BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
National Institute of Mental Health
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
. - Early Psychosis Intervention Network (EPINET): Practice-Based Research to Improve Treatment Outcomes (R01 Clinical Trial Optional)
- Early Psychosis Intervention Network (EPINET): Data Coordinating Center (U24 Clinical Trial Not Allowed)
National Institute of Mental Health
- Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Science Research
Office of Research on Women's Health
.
Program Announcements
- NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
National Cancer Institute
- Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Not Allowed)
- Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Required)
Office of Behavioral and Social Science Research
National Center for Complementary and Integrative Health
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Research on Women's Health
- Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed)
- Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
National Cancer Institute
- NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
National Cancer Institute
- Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed)
National Institute on Aging
- Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed)
National Institute on Aging
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu